(3.238.186.43) 您好!臺灣時間:2021/02/25 02:25
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:林燕君
研究生(外文):YEN-CHUNG LIN
論文名稱:三環苯駢喃[3,4-b][1,4]衍生物之合成及其作為鉀離子通道促進劑之藥理研究
論文名稱(外文):Synthesis and Pharmacology of Tricyclic 1-Benzopyrano[3,4-b][1,4]Oxazine Derivatives as Potassium Channel Openers
指導教授:程正禹
指導教授(外文):CHEN-YU CHENG
學位類別:碩士
校院名稱:國立臺灣大學
系所名稱:藥學研究所
學門:醫藥衛生學門
學類:藥學學類
論文種類:學術論文
論文出版年:1998
畢業學年度:87
語文別:中文
論文頁數:85
中文關鍵詞:鉀離子通道促進劑六氫-苯駢喃[34-b][14]的衍生物光學活性(4aR10bR)-N-苯甲醯1234a510b-六氫-55-二甲-1-苯駢喃[34-b][14]-9(4aR10bR)-N-苯甲醯1234a510b-六氫-55-二甲-1-苯駢喃[34-b][14]-9老鼠肝門靜脈和膀胱逼尿肌三溴化硼苯醯氯抑制收縮
外文關鍵詞:potassium channel openerpotassium channel openerhexahydro benzopyrano[34-b][14] oxazine derivativesoptically active(4aR10aR)-N-benzoxyl-1234a510b-hexahydro-55-dimethyl-1-benzopyrano[34-b][14]oxazine-9-carbonitrilerat portal vein and KCl-stimulated rat detrusor stripboron tribromidebenzenesulfonyl chloride.spontaneous contracting
相關次數:
  • 被引用被引用:0
  • 點閱點閱:127
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
以鉀離子通道促進劑cromakalim為引導化合物,在本研究中合成了一系列具有光學活性的六氫-苯駢喃[3,4-b][1,4]的衍生物((+)-37a-c,(-)-38f-o及(-)-52),並以老鼠肝門靜脈和膀胱逼尿肌進行活性測試, 觀察其是否有抑制收縮的活性。

目標化合物中的(+)-37a-c為(4aR,10bS)-1,2,3,4a,5,10b-六氫-5,,5-二甲基-1-苯駢喃[3,4-b][1,4]-9((+)-41)的醯化產物,合成起始物環氧化合物(-)- 39是由6-氰基-2,2-二甲基-2H-1-苯駢喃經以Mn(salen)為催化劑的不齊氧化反應而來。接著以乙二醇胺( ethanolamine) 進行開環反應, 得到雙醇化合物(+)-40 。 再對雙醇中間體進行Mitsunobu 分子內環化, 則得到三環中間體 (+)-41 。化合物41分別與甲酸乙酸,丙酸和異丁醯氯反應則得到37a-c 。 本實驗室先前之研究發現(4aR,10bR)-N-苯甲醯1,2,3,4a,5,10b-六氫-5,,5-二甲-1-苯駢喃[3,4-b][1,4]-9(38e) 對膀胱具有選擇性的抑制收縮的活性。為了探討苯環上取代基的效應, 乃合成了化合物(-)-38f-o,化合物38f-n是由其(4a,10b)反式異構物((+)-50f-n)經鹼催化反應而得,化合物(-)-38o則是經由(-)-38j以三溴化硼進行去甲基化反應而得。目標化合物(-)-52為(-)-38e的類似物其合成是經由中間體(-)38b用鹽酸將其乙醯基水解後得到類化合物(-)-46,再與苯醯氯進行醯化反應而得。


依藥理活性結果38e對膀胱活性為 8.15 mM其選擇性(IC50,門靜脈/ IC50,膀胱 = 4.2倍) 。化合物38f-o在苯環上之不同取代基其對鉀離子通道活性有顯著影響,其中間位有甲基取代的38g對肝門靜脈有最高的活性(0.54mM)及選擇性( IC50 rato = 0.002) 。而對位有含未鍵接電子取代者對膀胱逼尿肌的活性較好, 如4-溴衍生物38k ( 2.0 mM )及4-基衍生物38o (3.8 mM),38o之選擇性最高(IC50 ratio = 19.6),苯磺化合物52在膀胱之活性僅比38e略低(11.6 mM)但選擇性較高(IC50 ratio =10.3)。

As rigid analogs of the prototype potassium channel opener (POC) cromakalim, a series of optically active hexahydro benzopyrano[3,4-b][1,4] oxazine derivatives have been synthesized. The PCO activity of target compounds were evaluated in vitro with preparations of spontaneous contracting rat portal vein and KCl-stimulated rat detrusor strip.

Target compounds (+)-37a-c are acylation products of (4aR,10aS)-1,2,3,4a,5,10b-hexahydro-5,5-dimethyl-1-benzopyrano[3,4-b][1,4] oxazine-9-carbonitrile ((+)-41). The starting epoxide (-)-39, prepared form 6-cyano-2,2-dimethyl-2H-1-benzopyran via Mn(salen) catalyzed asymmetric epoxidation, was subjected to ring-opening by 2-aminoethanol to give the diol intermediate (+)-40. Compound (+)-40 underwent intramoleculor cyclization under Mitsunobu condition to form the tricyclic intermediate (+)-41. Acylation of 41 with acetic formic anhydride, propionic anhydride, and isobutyryl chloride respectively, provided the target compounds (+)-37a-c. Earlier studies in our laboratory resulted in the identification of (4aR,10aR)-N-benzoxyl-1,2,3,4a,5,10b-hexahydro-5,5-dimethyl-1-benzopyrano[3,4-b][1,4]oxazine-9-carbonitrile ((-)-38e) as a bladder-selective potassium channel opener. To study the effects on PCO activity of different substitutents on the benzene ring of 38e, compounds (-)-38f-o were synthesized. Compound 38f-n were prepared from their corresponding (4aS,10aR)- or trans isomers (+)-50f-n. Compound 38o was obtained form 38j via O-demethylation with boron tribromide. Compound 52, the sulfonamide analog of amide(-)-38e, was obtained form 38b via hydrolysis with HCl and the subsequent reaction with benzenesulfonyl chloride.

Among the target compounds, 38g with a meta-methyl - substituent showed the highest potency (IC50 = 0.54 mM ) and selectivity (IC50, portal vein / IC 50,bladder =0.002) on the portal vein. Compounds with para-substituents having lone-pair electrons showed improved activity on the bladder, such as the 4-bromo analog 38k (IC50,bladder = 2.0 mM; IC50 ratio = 4 ) and the 4-OH analog 38o (IC50,bladder = 3.8 mM; IC50 ratio = 19.6). Benzenesulfonamide 52 was found to be bio-isosteric with benzamide 38e, with slightly lower IC50 (11.6 mM) and higher selectivity (IC50 ratio = 10.3).

中文摘要 1
英文摘要 3
一‧背景及動機 6
二‧結果與討論 26
化學合成 26
藥理 39
三‧結論 43
四‧實驗部分 45
溶劑及藥品來源 45
一般儀器及方法 46
合成步驟 49
藥理實驗 79
五‧參考文獻 81
六‧附圖 89
圖 目 錄


圖1: 鉀離子通道促進劑與心肌或平滑肌細胞之間的電生理效應 9
圖2: Cromakalim 類似化合物之結構通式14
圖3: Cromakalim的X-光繞射晶體結構25
圖4: 化合物37a的X-光繞射晶體結構28
圖5: 化合物38k的X-光繞射晶體結構34
圖6: 化合物38n的X-光繞射晶體結構35
圖7: 51e和38e分子最低能量構形36
表 目 錄

表一:化合物37a-c及其相關化合物影響老鼠肝門靜脈和膀胱逼尿
肌收縮的藥理活性41
表二:化合物38e-f和化合物52抑制老鼠肝門靜脈和膀胱逼尿肌
縮的藥理活性42
路 徑 目 錄

路徑1: 目標化合物37a-c的合成27
路徑2: 化合物38a-e的合成30
路徑3: 化合物47的合成31
路徑4: 目標化合物38e-o的合成33
路徑5: 目標化合物52的合成之一 37
路徑6: 目標化合物52的合成之二 38

1. Brocklehurst. J.C. Urology in the elderly.1984
2. Cook, N. S. The Pharmacology of Potassium Channels and Their Therapeutic Potential. Trends Pharmacol. Sci. 1988, 9, 21-28.
3. Yoshizumi. K,; Ikeda. S.; Goto. K.; Morita. T,; Nisimura. N.; Sukamoto. T. and Yoshino. K. Synthesis and Structure-Activity Relation of Novel Phenylcyanoguanidine Derivatives as Potassium Channel Openers. Chem. Pharm. Bull.1996, 44, 2042-2050.
4. Taira, N. Similarity and Dissimilarity and Mechanism of Action between Nicorandil and Classical Nitrates: An overview. J.Cardiovasc Pharmacol.1978,10, S1-9
5. Steinberg, M. I.; Robertson, D. W. The Body*s Potassium Channels. CHEMTECH 1990, 432-438.
6. Noma, A. ATP-regulated K+ Channels in Cardiac Muscle. Nature 1983, 305, 147-148.
7. Spruce, A. E. ; Standen, N. B.; Stanfield, P. R. Studies of the Unitary Properties of Adenosine-5*-Triphosphate-Regulated Potassium Channels of Frog Skeletal Muscle. J. Physiol. 1987, 382, 213-236.
8. Cook, D. L.; Hales, C. N. Intracellular ATP directly Blocks K+ Channels in Pancreatic b-cells. Nature 1984, 311, 271.
9. Wang, W.; Sackin, H.; Giebisch, G. Renal Potassium Channels and Their Regulation. Ann. Rev. Physiol. 1992, 54, 81-96.
10. Ben-Ari, Y.; Krnjevic, K.; Crepel, V. Activators of ATP-Sensitive K+ Channels Reduce Anoxic Depolarization in CA3 Hippocalpal Neurons. Neuroscience 1990, 37, 55-60.
11. Bernardi, H.; Fosset, M.; Lazdunsk, M. Characterization, Purification and Affinity Labeling of The Brain [3H] Glibenclamide-Binding Protein, A putative Neuronal ATP-Regulated K+ Channel. Proc. Natl. Acad. Sci. USA 1988, 85, 9816-9820
12. Atwal, K. S. Advances in The Structure-Activity Relationships, Mechanisms of Action, and Therapeutic Utilitres of ATP-Sensitive Potassium Channel Openners. Drug Development Res. 1994, 33, 250-262.
13. Special Issue on ATP Sensitive Potassium Channels. Cardiovasc. Res. 1984, 28, 726-930.
14. Evans, J. M.; Fake, C. S.; Hamilton, T. C.; Poyser, R. H. and Watts, E. A. Synthesis and Antihypertensive Activity of Substituted trans-4-Amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3-ol. J. Med. Chem. 1983, 26, 1582-1589.
15. Evans, J. M.; Fake, C. S.; Hamilton, T. C.; Poyserr, R. H.; Showell, G. A. Synthesis and Antihypertensive Activity of 6,7-Disubstituted trans-4-Amino-3,4-dihydro-2, 2-dimethyl-2H-1-benzopyran-3-ol. J. Med. Chem. 1984, 27, 1127-1131.
16. Ashwood, V. A.; Buckingham, R. E.; Cassidy, F.; Evanss, J. M.; Faruk, E. A.; Hamilton, T. C.; Nash, D. J.; Stemp, G.; Willcocks, K. Synthesis and Antihypertensive Activity of 4-(Cyclicamido)-2H-1-benzopyrans. J. Med. Chem. 1986, 29, 2194-2201.
17. Hamiltonm T. C.; Weir, S. W. and Weston, A. H. Comparison of The Effects of BRL 34915 and Verapamil on Electrical And Mechanical Activity in Rat Portal Vein. Br. J. Pharmac. 1986, 88, 103-111.
18. Zografos, P.; Li, J. H.; Kau, S. T. Comparison of The in Vitro Effects of K+ Channel Modulators on Detrusor and Portal Vein Strips form Guinea Pigs. Pharmacol.1992, 45, 216-230
19. Ashwood, V. A.; Cassidy, F.; Coldwell, /m. C.; Evanss, J. M.; Hamilton, T. C.; Howlett, D. R.; Smith, D. M.; Stemp, G. Synthesis and Antihypertensive Activity of 4-(Substitutedcarbonylamido)-2H-1-benzopyrans. J. Med. Chem. 1990, 33, 2667-2672.
20. Burrell, G.; Cassidy, F.; Evans, J. M.; Lightowler, D.; Stemp, G. Variation in the Aromatic Ring of cromakalim : Antihypertensive Activity of Pyranopyridines and 6-Alkyl-2H-1-benzopyrans. J. Med. Chem. 1990, 33, 3023-3027.
21. Atwal, K. S.; Ferrara, F. N.; Ding, C. Z.; Grover, G. J,; Sleph, P. G.; Dzwonczyk, S,; Baird, A. J. and Normandin, D. E. Cardioselective Antiischemic ATP-Sensitive Potassium Channel Openers. 4. Structure-Activity Studied on Benzopyranyl-cyanoguanidines : Replacement of the Benzopyran Portion. J. Med. Chem. 1996, 39, 304-313.
22. Thomas, W. A.; Whitcombe, I. W. A. Conformational Behaviour of cromakalim and Related Potassium Channel Activators. J. Chem. Soc. Chem. Commum, 1990, 528-529.
23. Dalonzo. A. J; Darbenzio. R. B.; Swter. J. C.; Hess. T. A.; Grover. G. J.; Sleph. P.G. Normandin. D. E. and Lodge. N.J. A Comparison Between the Effect of BMS-180448, a Novel K+ Channel Opener, andCromakalim in Rat and Dog. Eur. J. Pharmacol, 1995, 294, 271-280.
24. Sato, H.; Koga, H.; Ishizana, T.; Makino, T.; Kuromaru, K.; Taka, N.; Takahashi, T.; Sato, T.; Nabata, H. Bioorg. Med. Chem. Lett. 1993, 3, 2624-2627.
25. Tamura, K.; Suzuki, Y.; Yoshida, S.; Nabata, H. Action of KC-399, a Newly Synthesized Potassium Channel Opener, on Mechanical Activity and 86Rb Efflux in Rat Aorta. J. Cardiovasc. Pharmacol. 1994, 23, 220-226.
26. Uchida, W.; Hirano, Y.; Shirai, Y.; Taguchi, T.; Masuda, N.; Shibasaki, K.; Hirano, S.; Matsumoto, Y.; Tsuzuki, R.; Yanagisawa, I.; Satoh, N.; Takenaka, T. Potassium Channel-Opening and Vasorelaxant Profiles of a Novel Compound YM099 in Rat Isolated portal Vein and Rabbit Isolated Aorta. Arch. Int. Pharmacodyn. 1994, 327, 330-343.
27. Uchida, W.; Hirano, Y.; Taguchi, T.; Masuda, N.; Shiral, Y.; Satoh, N.; Takenaka, T. Cardiovascular Effect of YM099, a Novel K+ Channel Openner, in Anesthtized and Conscious Dog. Eur. J. Pharmacol, 1994, 264, 285-293.
28. Uchida, W.; Masuda, N.; Taguch, T., Shibasaki, K.; Shirai, Y.; Asano, M.; Matsumoto, Y.; Tsuzuki, R.; Fujikira, T.; Takeraka, T. Pharmacologic Profiles of YM-934, a Novel Potassium Channel Opener. J. Cardiovasc, Pharmacol. 1994, 23, 180-187.
29. Yamada, M.; Terzic, A.; Findlay, I.; Jahangir, A.; Shen, W.K.; Kurachi, Y. Antihypertensive and Cardiovascular Effect of a New Potassium Channel Opener,TCV-295, in Rats and Dogs. J. Pharmacol. Exp. Ther. 1993, 267, 1544-1553.
30. Russell, K.; Brown, F. J.; Warwick, P.; Forst, I.; Grant, T.; Howe, B.;Kau, S. T.; Li, J. H.; McLaren, F. M.; Shapiro, H. S.; Trivedi, S. A Highly Potent Series of Fluoroalkyl Benzoxazine Pyridine Potassium Channel Openers. Bioorg. Med. Chem. Lett. 1993, 3, 2727-2728
31. Burrell, G.; Evanss, J. M.; Hardley, M. S.; Hicks, F.; Stemp, G. Benzopyran Potassium Channel Activators Related To Cromakalim-Heterocyclic Amide Replacements At Position 4. Bioorg. Med. Chem. Lett. 1994, 4, 1285-1290
32. Damiano, B. P.; Giardino, E. C.; Haertlein, B. J.; Stump, G. L.; Mitchell, J. A.; Falotico, R. Cardiovascular Profile of RWJ29009, a New Potassium Channel Activator, in Anesthetized and Conscious Dog. J. Cardiovasc. Pharmacol. 1994, 23, 300-310.
33. Katz, L. B.; Giardino, E. C.; Salata, J. J.; Moore, J. B.; Falotico, R. RWJ26629, a New Potassium Channel Opener and Vascular Smooth Muscle Relaxant : APotential Antihypertensive and Antiaginal Agent. J. Pharmacol., Exp. Ther. 1993, 267, 648-656.
34. Itoh, T.; Ito, S.; Shafiq, J.; Suzuki, H. Effect of a Newly Synthesized K+ Channel Opener, Y-26763, on Noradrenaline-Induced Ca2+ Mobilization in Smooth Muscle of the Rabbit Mesenteric Artery. Br. J. Pharmacol. 1994, 111, 165-172
35. Terzic, A.; Jahangir, A.; Kurachi, Y. HOE-234, a Second Generation K+ Channel Opener, Antagonizes the ATP-Dependent Gating of Cardiac ATP-Sensitive K+ Channels.J. Pharmacol. Exp. Ther. 1994, 268, 818-825.
36. Kamei, K.; Yoshida, S.; Imagawa, J. I.; Nabatu, H.; Kuriyawa, H. Regional and Species Difference in Glyburide-Sensitive K+ Channels in Airway Smooth Muscles as Estimated frim Actions of KC-128 and Levcromakalim. Br. J. Pharmacol. 1994, 113, 889-897.
37. Kusumoto, K.; Awane, Y.; Kitayoshi. T.; Fujiwara, S.; Hashigushi, S.; Teraahita.; Shiraishi, M.; Watanabe, T. J., Pharmacologic Profiles of YM934, a Novel Potassium Channel Opener.; J. Cardiovasc. Pharmacol. 1994, 23, 180-187.
38. Smith, D. G.; Buckle, D. R.; Faller, A. and Pinto, I. Pyrrole Analogues of the Pyrrolidinone Moiety of the Potassium Channel Activator Cromakalim as Relaxant of Guinea Pig Trachealis. L. Bioorg Med. Chem. Lett., 1992, 2, 1595-1598.
39. Yoo, S. E.; Kim, S. J.; Shin, H. S.; Hong, K.W. Benzopyran Sulfoxide Derivatives as New Potassium Channel Activator. Bioorg. Med. Chem. Lett., 1993, 3, 553-554.
40. Gadwood, R. C.; Kamdar, B. V.; Cipkus Dubray, L. A.; Wolfe, M. L.; Smith, M. P.; Watt, W.; Mizsak, S. A.; Groppi, V. E. Synthesis and Biological Activity of Spirocyclic Benzopyran Imidazolone Potassium Channel Openners. J. Med. Chem. 1993, 36., 1480-1487.
41. Gadwood R. C.; Thomasco, L. M.;Groppi, V. E.; Burrnett, B. A.; Humphrey, S. J.; Smith, M. P. and Watt, W., 207th ACS National Meeting, San Diegp, CA, March 13-18, Abstract 223, 1994.
42. Almansa, C.; Gomez, L. A.; Cavalacanti, F. L.; Rodriguez, R.; Carceller, E.; Bartroli, J.; Garcia-R., J. and Forn, J. 2,2-Dialkylnaphthalen-1-ones as New Potassium Channel Activators. J. Med. Chem., 1993, 36, 2121-2133.
43. Perez-Vizcaino, F.; Casis, O.; Rodriguez, R.; Gomez, L. A.; Garcia Rafanell, J. and Tamargo, J. Effect of Novel Potassium Channel Opener, UR-8225, on Contractile Responses in Rat Isolated Smooth Muscle. Br. J. Pharmacol. 1993, 110, 1165-1171.
44. Berthelon, J-J.; Brunet, M.; Noblet, M.; Durbin, P. Guerrier, D. and Luong, T. Patent Application, WO/9413658, 1994.
45. Empfield, J. R.; Mayhugh, D.; Ohnmacht, C. J.; Frank, C. ; Grant, T.; Li, J. 4-Sulfonamidoanilide Tertiary Carbinols: A Novel Series of Potassium Channel Openers. Bioorg. Med. Chem. Lett. 1997, 7, 775-778.
46. Howe,B. B; Halterman,T. J; Yochim, C.L; Do, M. L; Pettinger, S. J ; Stow, R. B; Ohnmacht, C. J; James, K. R; Trainor, D. A; Browin, F. J; Kau,S.T. ZENECA ZD6169 : A Novel KATP Channel Opener with in Vivo Selectivity for Urinary Bladder. J. Pharmacol. Exp.Ther.1995, 274, 884-890.
47. Cassidy, F.; Evanss, J. M.; Smith, D. M.; Stemp, G.; Edge, and Williams, D. J. Conformational Analysis of the Novel Antihypertensive Agent cromakalim (BRL 34915). J. Chem. Soc. Chem. Commun. 1989, 377-378.
48. Attwood, M. R.; Jones, P. S.; Kay, P. B.; Paciorek, P. M. and Redshaw, S. The Design of a Novel Class of Potassium Channel Activiting Drugs, 2-(2,2-Dimethylbenzopyran-4-yl)-Pyridine-1-Oxides. Life Sciences, 1991, 48, 803-810.
49. Part of this work has been published. See: Cheng, C.Y.; Chiu, H. I.; Chang, M. ; Lin, Y. C.; Tsai, M. C.; Yu, H. C. Synthesis of 2,3,4a,11b-Tetrahydro-oxazino{2,3,-c}benzopyran-9-carbonitriles as ATP-Sensitive Potassium Channel Openers. Bioorg. Med. Chem. Lett. 1998, 8, 463-468.
50. Chang, M. J. Ph. D. Thesis, Synthesie and Pharmacology of Novel Benzopyran Derivatives as Potassium Channel Activators. Jan. 1997
51. Lee, N. H.; Muci, A. R. ; Jacobsen, E. N. Enantiomerically Pure Exoxychromans via Asymmetric Catalysis. Tetrahedron Lett. 1991, 32, 5055-5058.
52. Houge-Frydrych, C. S. V.; Pinto, I. L. An UmusualHydroxyl Inversion By DAST . Tetrahedron Lett. 1989, 30, 3349-3350.
53. Fukuyama, T.; Jow, C.-K.; Cheung, M. 2- and 4-Nitrobenzenesulfonamides: Exceptionally Versatile Means for Preparation of Secondary Amines and Protection of Amines. Tetrahedron Lett. 1995, 36, 6373-6380.
54. 化合物37d-e及化合物38a-e係由邱欣怡同學所製備的.
55. Quast, U.; Villhauer, E. B. The Individual Enantiomers of Cis-Coromakalim Possess K+ Channel Opening Activity. Eur. J. Pharmacol. 1993, 245, 165-171.
56. Still, W. C.; Kahn, A. Rapid Chromatographic Technique for
Preparative Separations with Moderate Resolution.
J. Org. Chem.1978, 4, 73-80.

QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關期刊
 
系統版面圖檔 系統版面圖檔